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Particulate guanylate cyclase from bovine adrenal cortex can be stimulated by ANF. A 2-fold stimulation 
of the enzyme was obtained with 100 nM ANF and a half-maximal stimulation, with a 5 nM dose. The 
stimulation by ANF persisted for at least 30 min. Various detergents, such as Triton X-100, Lubrol PX, 
cholate, CHAPS, d~~tonin and zwittergent, stimulated several-fold the activity of particulate guanylate 
cyclase. However. only Triton X-100 dispersed particulate guanylate cyclase without affecting its response 
to ANF. The dose-response curve of ANF stimulation of the particulate and the Triton X-100 dispersed 
enzyme was similar. The dispersion of a fully responsive guanylate cyclase to ANF will help us to uncover 
the type of interactions between guanylate cyclase and ANF. It will also be used as a first step for the purifi- 
cation of an ANF-sensitive particulate guanylate cyclase. 
1, INTRODUCTION 
Specific granules from m~mmaIian atria1 car- 
diocytes contain potent natriuretic, diuretic and 
vasodilatory peptides [1,2], which have recently 
been purified, synthesized [3,4] and their gene 
cloned {5,6]. Several other functions, such as in- 
hibition of aldosterone and co&sol secretion from 
the adrenal cortex, have also been described 
[7-101. We have demonstrated that atria1 
natriuretic factor (ANF) induces a significant in- 
crease of cGMP levels in plasma, urine and renal 
cells [11,12] and have proposed that cGMP is a 
mediator of the physiological effects of this pep- 
tide in specific target tissues f13f. Recently, we 
have shown in clinical studies that cGMP can also 
be used as a marker of ANF’s action [14]. 
ANF increases cGMP levels via a direct stimula- 
tion of particulate guanylate cyclase, a glycopso- 
tein different from its soluble counterpart which is 
a hemeprotein [13,15-171. Until reeently, no 
agonist was shown for particulate guanylate 
cyclase other than heat-stable nterotoxins from E. 
coii and Y. enterocofitica acting in the intestine 
f18f. ANF and its related peptides, the atriopeptin, 
are thus the first endogenous agonist for this par- 
ticular enzyme. Recently, ANF was shown to 
stimulate particulate guanylate cyclase in the rat 
and bovine adrenal cortex [ 15,191. Using bovine 
adrenal cortex as an abundant source, we have 
undertaken work to purify particulate guanylate 
cyclase responsive to ANF. 
This report describes how particulate guanylate 
cyclase from the bovine adrenal cortex can be 
dispersed by Triton X-100 and retain its full sen- 
sitivity to ANF stimulation. 
2. MATERIALS AND METHODS 
2.1. ANF sources 
Synthetic rat ANF (Arg 101-Tyr 126) was 
donated by Merck Sharp and Dohme Research 
Laboratories (West Point, USA) or purchased 
from 1’Institut Armand Frappier (Montreal, 
Canada). 
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Guanylate cyclase activity was assessed essential- 
ly as described [20]. The reaction mixture (0.1 ml) 
contained 5 mM creatine phosphate, 50 /rg 
creatine phosphokinase, 1 mM I-methyl-3-iso- 
butylxanthin~, 5 mM MnCI2, 1 mM GTP-Mn, 
2 mM cGMP, 0.1-0.5 &i [a-32P]GTP in 50 mM 
Tris buffer (pH 7.5) and 1OOyg proteins. Incuba- 
tions were stopped after 30 min at 37°C by the ad- 
dition of 500 ,uI of 120 mM zinc acetate and 600 ~1 
sodium carbonate. After centrifugation, the 
[32P]cGMP was further purified on Dowex WX 4 
and alumina columns. Recovery was monitored 
with added [3H]cGMP and was between 55 and 
65%. 
2.3. Enzyme preparation 
The cortex from bovine adrenal glands was 
homogenized with a polytron homogenizer and 
centrifuged at 1500 x g for 30 min. The pellet was 
resuspended in a 20 mM triethanoIamine/HCl 
(TEA) buffer (pH 7.5) containing 1 mM EDTA 
and 250 mM sucrose. Particles were obtained by 
%-fold high-speed ~entrifugation (105000 x g, 
60 min) and resuspended in 20 mM TEA (pH 7.0) 
containing 1 mM EDTA and 50pg/ml leupeptin. 
2.4. Dispersion of particulate guanylate cyclase 
The pellet of the bovine adrenal cortex par- 
ticulate preparation was resuspended at a protein 
concentration of 10 mg/ml in 20 mM tri- 
ethanolamine/HCl (pH 7.5) containing I mM 
EDTA and .50pg/ml leupeptin and incubated for 
60 min at 4°C with different detergents. The 
material was then centrifuged at 105000 x g for 
60 min. Washed particles represent he membrane 
preparation before incubation with detergents, 
whereas the supernatant and pellet represent frac- 
tions of solubilized membranes following 
detergent incubation and high speed centri- 
fugation. 
Proteins were measured by the method of Pet- 
terson [21] to avoid the interference caused by the 
different detergents. Bovine serum albumin was 
used as standard. 
3. RESULTS AND DISCUSSION 
3.1. S~~rnu~a~ion of par~~c~~afe guan_~~a~e cyckzse 
from bovine adrenal cortex by ANF 
At about the 5 nM dose level, ANF half- 
IANF] fM1 
20 30 
INCUBATION TIME (mffil 
Fig.1. (a) Dose-response curve of ANF stimulation of 
guanylate cyclase activity in membrane preparations 
from bovine adrenal cortex. The membranes were 
processed as described in section 2. Guanylate cyclase 
activity was measured after 30 min of incubation using 
GTP-Mn (1 mM) as substrate in the presence of excess 
Mn2* (5 mM). (b) Time course of guanylate cyclase 
activity in bovine adrenal cortex membranes in the 
absence and presence of ANF (1 PM). (c) Effect of 
various substrate concentrations on the activity of 
guanylate cyclase in membranes from bovine adrenal 
cortex in the absence and presence of ANF (1 pM). 
maximally activated particulate guanylate cyclase 
in the bovine adrenal cortex. A 2-fold stimulation 
of the enzyme was achieved with 100 nM ANF 
(fig.la). Guanylate cyclase activity in this tissue 
was linear with time for at least 60 min, and the 
ANF-induced stimulation was stable for at least 
30 min (fig.lb). A 5-lo-fold increase of par- 
ticulate guanylate cyclase activity was recently 
observed with atriopeptin II in the rat adrenal cor- 
tex 1191, but this stimulation was decrea ed after 
2.5 min. ParticuIate guanylate cyclase 
positive cooperative kinetics with GT -Mn as 
Jk 
exerted 
substrate. As illustrated in fig. lc, ANF di not ap- 
pear to alter the enzyme’s kinetic behavio but in- 
creased its maximal velocity. Guanylate cyclase ac- 
tivity, with GTP-Mg as substrate, was less than 
10% of that obtained with GTP-Mn. The enzyme 
was also stimulated 2-3-fold by ANF with GTP- 
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GC activity Stimulation GC activity GC activity GC Total GC 
in washed (-fold) in in dispersion protein enrichment 
particles loOOOOxg 1OOOOOxg (070) dispersion 
supernatant pellet (VrJ) 
7.1 rfc 0.8 - 0.7 5.7 - 
0.1 14.9 2.1 6.7 8.4 44 27 1.6 
1.0 26.3 3.7 23.2 7.0 17 36 2.1 
0.1 13.5 1.9 6.4 9.1 41 20 2.1 
1.0 27.7 3.9 7.9 23.8 25 16 1.6 
0.1 14.2 2.0 4.3 8.4 34 32 1.1 
1.0 10.7 1.5 9.8 2.7 78 81 1.0 
0.1 13.5 1.9 4.4 10.9 29 13 2.2 
1.0 27.0 3.8 18.0 19.8 50 30 1.7 
0.1 11.4 1.6 1.5 19.6 7.1 12 - 
1.0 42.8 6.0 33.6 36.0 48 31 1.5 
0.1 11.6 1.6 4.2 10.6 30 26 1.2 
1.0 95.6 13.4 79.6 16.8 83 50 1.7 
GC activity is expressed in pmol cGMP vmin-’ . 10 pl-’ 
Mg as substrate (not shown). Particulate guanylate 
cyclase was autoactivated by incubation at 3’7°C in 
the absence of substrate. During this autoactiva- 
tion, stimulatory impact of ANF on the enzyme 
was lost (not shown). 
3.2. Effect of various types of detergents on 
particulate guanylate cydase 
The influence of several detergents was studied 
during the attempt o solubilize ANF-sensitive par- 
ticulate guanylate cyclase from the bovine adrenal 
cortex. All the detergents tested, i.e. Triton X-100, 
Lubrol PX, cholate, CHAPS, digitonin and zwit- 
tergent, stimulated several-fold the activity of par- 
ticulate guanylate cyclase with the zwittergent 
types being the most potent (table 1). Triton X-100 
and zwittergent effectively dispersed the enzyme 
(77 and 83%, respectively) with a 2-fold enrich- 
ment of specific activity over total membrane 
proteins. 
3.3. Characteristics of the effect of Triton X-100 
on partiedate guanylate cyclase 
Among all the detergents tested, only Triton 
X-100 dispersed particulate guanylate cyclase 
without affecting its response to ANF (fig.2). 
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Fig.2. Effect of different detergents on stimulation of 
guanylate cyclase activity by ANF. Washed particles of 
bovine adrenal cortex were resuspended at a protein 
concentration of 10 mg/ml as described in section 2 and 
incubated for 60 min at 4°C with different detergents. 
Guanylate cyclase activity was measured before (control) 
and after the 60 min incubation with 1.0% of various 
detergents in the absence or presence of 1 ,&I ANF. The 
results are expressed in % of guanylate cyclase activity 
measured in the presence of ANF from basal guanylate 
cyclase incubated without ANF. The data are 
representative of a typical experiment. 
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Stimulation of the enzyme by ANF when it was 
dispersed with CHAPS or Lubrol PX was reduced 
to only 38 and 18%) respectively, in comparison to 
the native enzyme or dispersion with Triton X-100. 
ANF completely lost its ability to activate par- 
ticulate guanylate cyclase dispersed with cholate, 
zwittergent, or digitonin. 
These results correlate with those of the 
solubilized ANF receptors in rat glomeruli (F. Car- 
rier et al., in press). CHAPS and Triton X-100 
were the most suitable agents for solubilization of 
membrane proteins, causing no loss of ANF 
receptors. 
Fig.3 shows the dispersion profile of guanylate 
cyclase from bovine adrenal cortex particles as a 
function of the Triton X-lOO/protein ratio (w/w). 
Optimal dispersion of guanylate cyclase occurred 
at a Triton X-lOO/protein ratio of 2.0; a maximum 
of 30% of total membrane protein solubilization 
was obtained with Triton X-100 in this tissue. A 
maximal 8-fold stimulation of guanylate cyclase 
activity was observed with Triton X-100 (fig.4). At 
a Triton X-loo/protein ratio of 2.0, guanylate 
cyclase was still fully responsive to ANF. ANF 
IB$!gxJ (;) 
Fig.3. Solubilization profile of protein and guanylate 
cyclase from bovine adrenal cortex particles as a 
function of the Triton X-lOO/protein ratio. The adrenal 
cortex particulate preparation was incubated with 
various amounts of Triton X-100 for 60 min at 4“C as 
described in section 2. The material was then centrifuged 
at 105 000 x g for 60 min, and guanylate cyclase activity 
(o--o) and protein concentration (M) were 
measured in the high-speed supernatant. 
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Fig.4. Stimulation of particulate guanylate cyclase by 
ANF after Triton X-100 activation. Particulate 
preparation was incubated for 60 min at 4°C with 
increasing concentrations of Triton X-100 and guanylate 
cyclase activity (M) was measured in the absence or 
presence of 1 PM ANF. ANF stimulation (- --) was 
calculated from a control particulate preparation 
incubated with ANF but without prior incubation with 
Triton X-100. 
Fig.5. Dose-response curve of ANF stimulation of 
guanylate cyclase in washed particles from the adrenal 
cortex (m) and in a high-speed supernatant 
(105000 x g, 60 min) of washed particles preincubated 
with a Triton X-lOO/protein ratio of 1.0 (o--o). 
stimulation was lower (60070) but still persistent at 
the highest Triton X-lOO/protein ratio of 10. 
Dispersed guanylate cyclase appeared to retain 
at least some properties of the particulate enzyme 
(fig.5). The dose-response curve of ANF stimula- 
tion of dispersed particulate guanylate cyclase was 
similar to that of the native enzyme, and in most 
cases, maximal ANF activation was even 
somewhat greater with the dispersed preparation 
than with the particulate enzyme. 
Whether the receptor molecule is a part of 
guanylate cyclase remains to be clarified, but our 
first results on the dispersion of fully guanylate 
cyclase responsive to ANF are compatible with at 
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least a close association of the 2 entities. 
Solubilization of a functional ligand-receptor com- 
plex is usually difficult to accomplish. For exam- 
ple, in the case of adenylate cyclase, it was found 
that its hormonal responsiveness cannot be 
measured with most detergents, including Triton 
X-100 f22]. The similitude between the solubiliza- 
tion of ANF receptors from rat glomeruli and that 
of particulate guanylate cyclase from the bovine 
adrenal cortex supports the hypothesis that they 
are part of the same molecule. Further evidence is 
provided by a comparison of the apparent 
molecular masses of the 2 entities. Thus, par- 
ticulate guanylate cyclase from sea urchin sperm 
migrated as a single band of 135 kDa after SDS gel 
electrophoresis [23], whereas the size of the la- 
belled ANF receptor was estimated to be 130 kDa 
[24] or 140 kDa [25] by gel electrophoresis. 
The fact that we can disperse guanylate cyclase 
fully responsive to ANF gives us a tool to explore 
some characteristics of the interaction between 
particulate guanylate cyclase and its stimulator. It 
constitutes a first step toward the purification of 
this enzyme. 
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